Journal
British Journal of Cancer
Publication Date
2013
Volume
108
Issue
7
Inclusive Pages
1480-1487
Document Type
Open Access Publication
DOI
10.1038/bjc.2013.80
Rights and Permissions
S D Soysal, et al. EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer. British Journal of Cancer (2013) 108, 1480–1487. doi:10.1038/bjc.2013.80 www.bjcancer.com Copyright 2013 Cancer Research UK From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 16 April 2013 This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Recommended Citation
Soysal, Savas D.; Muenst, Simone; Barbie, Thanh U.; Fleming, Timothy P.; Gao, Feng; Spizzo, Gilbert; Oertli, Daniel; Viehl, Carsten T.; Obermann, Ellen C.; and Gillanders, William E., "EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer." British Journal of Cancer. 108, 7. 1480-1487. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/4052
